A new paradigm for topical generic drug products: Impact on therapeutic access - 26/02/20
Funding sources: None. |
|
Conflicts of interest: None disclosed. |
|
The views expressed in this paper do not reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government. |
|
IRB approval status: Not applicable. |
|
Reprints not available from the authors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?